A stochastic model for immunotherapy of cancer
Open Access
- 11 April 2016
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , 24169
Abstract
We propose an extension of a standard stochastic individual-based model in population dynamics which broadens the range of biological applications. Our primary motivation is modelling of immunotherapy of malignant tumours. In this context the different actors, T-cells, cytokines or cancer cells, are modelled as single particles (individuals) in the stochastic system. The main expansions of the model are distinguishing cancer cells by phenotype and genotype, including environment-dependent phenotypic plasticity that does not affect the genotype, taking into account the effects of therapy and introducing a competition term which lowers the reproduction rate of an individual in addition to the usual term that increases its death rate. We illustrate the new setup by using it to model various phenomena arising in immunotherapy. Our aim is twofold: on the one hand, we show that the interplay of genetic mutations and phenotypic switches on different timescales as well as the occurrence of metastability phenomena raise new mathematical challenges. On the other hand, we argue why understanding purely stochastic events (which cannot be obtained with deterministic models) may help to understand the resistance of tumours to therapeutic approaches and may have non-trivial consequences on tumour treatment protocols. This is supported through numerical simulations.Keywords
All Related Versions
This publication has 38 references indexed in Scilit:
- Intra-tumour heterogeneity: a looking glass for cancer?Nature Reviews Cancer, 2012
- Nonheritable Cellular Variability Accelerates the Evolutionary Processes of CancerPLOS Biology, 2012
- The tumor microenvironment is a dominant force in multidrug resistanceDrug Resistance Updates, 2012
- Clonal evolution in cancerNature, 2012
- Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer CellsCell, 2011
- Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR InhibitorsScience Translational Medicine, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Accumulation of driver and passenger mutations during tumor progressionProceedings of the National Academy of Sciences, 2010
- Polymorphic evolution sequence and evolutionary branchingProbability Theory and Related Fields, 2010
- A Limit Theorem for Multidimensional Galton-Watson ProcessesThe Annals of Mathematical Statistics, 1966